GLP1R and type 1 diabetes mellitus: For example, it has been reported that the combination therapy of GLP-1 receptor agonists (exendin-4) and PPI (omeprazole) is closely related to the enhanced insulin sensitization actions in streptozotocin (STZ)-induced T1D model mice (70).